Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

ADAMTS13: The surgeon's friend or foe.

Krige JE, Kahn D.

Arch Surg. 2012 Oct;147(10):917-8. doi: 10.1001/archsurg.2012.1231. No abstract available.

PMID:
23117829
2.

Increased von Willebrand Factor to ADAMTS13 ratio as a predictor of thrombotic complications following a major hepatectomy.

Kobayashi S, Yokoyama Y, Matsushita T, Kainuma M, Ebata T, Igami T, Sugawara G, Takahashi Y, Nagino M.

Arch Surg. 2012 Oct;147(10):909-17. doi: 10.1001/archsurg.2012.998.

PMID:
23117828
3.

Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction.

Kaikita K, Soejima K, Matsukawa M, Nakagaki T, Ogawa H.

J Thromb Haemost. 2006 Nov;4(11):2490-3. No abstract available.

4.

ADAMTS13 related markers and von Willebrand factor in plasma from patients with thrombotic microangiopathy (TMA).

Kobayashi T, Wada H, Nishioka N, Yamamoto M, Matsumoto T, Tamaru T, Nomura S, Masuya M, Mori Y, Nakatani K, Nishikawa M, Katayama N, Nobori T.

Thromb Res. 2008;121(6):849-54.

PMID:
17900666
5.

Changes in von Willebrand factor and ADAMTS13 during IVF.

Westerlund E, Antovic A, Hovatta O, Eberg KP, Blombäck M, Wallén H, Henriksson P.

Blood Coagul Fibrinolysis. 2011 Mar;22(2):127-31. doi: 10.1097/MBC.0b013e32834363ea.

PMID:
21192251
6.

ADAMTS-13 activity in von Willebrand disease.

Perutelli P, Amato S, Molinari AC.

Thromb Res. 2006;117(6):685-8. No abstract available.

PMID:
15993931
7.

Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.

Matsukawa M, Kaikita K, Soejima K, Fuchigami S, Nakamura Y, Honda T, Tsujita K, Nagayoshi Y, Kojima S, Shimomura H, Sugiyama S, Fujimoto K, Yoshimura M, Nakagaki T, Ogawa H.

Am J Cardiol. 2007 Sep 1;100(5):758-63.

PMID:
17719316
8.

Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis.

Rios DR, Fernandes AP, Figueiredo RC, Guimarães DA, Ferreira CN, Simões E Silva AC, Carvalho MG, Gomes KB, Dusse LM.

J Thromb Thrombolysis. 2012 May;33(4):416-21. doi: 10.1007/s11239-012-0719-5.

PMID:
22466813
9.

ADAMTS13 and Von Willebrand factor in patients undergoing hemodialysis.

Rios DR, Carvalho MG, Figueiredo RC, Ferreira CN, Rodrigues VL, Souza RA, e Silva AC, Fernandes AP, Gomes KB, Dusse LM.

J Thromb Thrombolysis. 2012 Jul;34(1):73-8. doi: 10.1007/s11239-012-0682-1.

PMID:
22298244
10.

Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.

Molvarec A, Rigó J Jr, Bõze T, Derzsy Z, Cervenak L, Makó V, Gombos T, Udvardy ML, Hársfalvi J, Prohászka Z.

Thromb Haemost. 2009 Feb;101(2):305-11.

PMID:
19190814
11.

ADAMTS 13 in non-thrombotic thrombocytopaenic purpura conditions.

Scully M, Liesner R, Burgess C, Lawrie A, Machin S.

Br J Haematol. 2008 Apr;141(2):262-5. doi: 10.1111/j.1365-2141.2008.06987.x. No abstract available.

PMID:
18307568
12.

ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin) and endothelial dysfunction in sepsis: marker or culprit?

Levy B, Lacolley P, Regnault V.

Crit Care Med. 2007 Oct;35(10):2453-4. No abstract available.

PMID:
17885389
13.

Essential domains of a disintegrin and metalloprotease with thrombospondin type 1 repeats-13 metalloprotease required for modulation of arterial thrombosis.

Xiao J, Jin SY, Xue J, Sorvillo N, Voorberg J, Zheng XL.

Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2261-9. doi: 10.1161/ATVBAHA.111.229609.

14.

Attack of the acronyms: TTP, VWF, ADAMTS-13 and SELDI-TOF-MS.

Auton M, Moake J.

J Thromb Haemost. 2006 Feb;4(2):329-32. No abstract available.

15.

von Willebrand factor-to-ADAMTS13 ratio increases with age in a Japanese population.

Kokame K, Sakata T, Kokubo Y, Miyata T.

J Thromb Haemost. 2011 Jul;9(7):1426-8. doi: 10.1111/j.1538-7836.2011.04333.x. No abstract available.

16.

ADAMTS-13: double trouble for von Willebrand factor.

Lenting PJ, Rastegarlari G.

J Thromb Haemost. 2010 Dec;8(12):2775-7. No abstract available.

PMID:
21188794
17.

Von Willebrand factor and ADAMTS13: a candidate couple for preeclampsia pathophysiology.

Stepanian A, Cohen-Moatti M, Sanglier T, Legendre P, Ameziane N, Tsatsaris V, Mandelbrot L, de Prost D, Veyradier A; ECLAXIR Study Group..

Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1703-9. doi: 10.1161/ATVBAHA.111.223610.

18.

ADAMTS13 and von Willebrand factor concentrations in patients with diabetes mellitus.

Skeppholm M, Kallner A, Kalani M, Jörneskog G, Blombäck M, Wallén HN.

Blood Coagul Fibrinolysis. 2009 Dec;20(8):619-26. doi: 10.1097/MBC.0b013e32832da183.

PMID:
19809308
19.

Opposite changes of ADAMTS-13 and von Willebrand factor after cardiac surgery.

Mannucci PM, Parolari A, Canciani MT, Alemanni F, Camera M.

J Thromb Haemost. 2005 Feb;3(2):397-9. No abstract available.

20.

Comparison of FRETS-VWF73 to full-length VWF as a substrate for ADAMTS13 activity measurement in human plasma samples.

Mahdian R, Rayes J, Girma JP, Houllier A, Obert B, Meyer D, Veyradier A.

Thromb Haemost. 2006 Jun;95(6):1049-51. No abstract available.

PMID:
16732393
Items per page

Supplemental Content

Support Center